Mrs Uniqua Annette Cheairs, CNM | |
6522 Grand Oak Ln, Southaven, MS 38672-2507 | |
(901) 297-9400 | |
Not Available |
Full Name | Mrs Uniqua Annette Cheairs |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 6522 Grand Oak Ln, Southaven, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124701388 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | CNM08098 (Tennessee) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Uniqua Annette Cheairs, CNM 6522 Grand Oak Ln, Southaven, MS 38672-2507 Ph: (901) 297-9400 | Mrs Uniqua Annette Cheairs, CNM 6522 Grand Oak Ln, Southaven, MS 38672-2507 Ph: (901) 297-9400 |
News Archive
According to World Health Organization researchers there is a rise in Australia in the number of seasonal influenza cases resistant to Tamiflu, the most commonly used antiviral drug. The rise in such cases involving the pandemic 2009 A (H1N1) flu strain, also known as swine flu, took place during Australia's most recent winter: May through August of 2011.
On Monday, September 27, researchers from Albert Einstein College of Medicine of Yeshiva University will hold a congressional briefing in Washington, D.C., aimed at focusing attention on the alarming global diabetes epidemic.
Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc., announced today that the U.S. Food and Drug Administration has approved ASTAGRAF XLTM (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil and corticosteroids, with or without basiliximab induction.
The 15th Medical Innovations Summit will take place at the Royal Society of Medicine on Saturday 16 September.
› Verified 6 days ago